Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cellulose sodium phosphate (substance) |
Is a |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Genitourinary drug (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium bicarbonate+citric acid 1.39g/1.14g soluble tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium citrate 3g/sachet granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium citrate mixture BPC |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely sodium citrate 4 gram/1 sachet granules for conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ammonium chloride mixture (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium citrate 3% irrigation solution (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miscellaneous cystitis remedies |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenazopyridine hydrochloride (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Medicinal product acting as urinary acidifier (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing phenazopyridine hydrochloride and sulfamethoxazole and trimethoprim |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Drugs for urinary retention |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Drugs for enuresis, urinary frequency and incontinence |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hyoscyamine- and phenazopyridine- and secbutabarbital-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bulking preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing sodium citrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenazopyridine- and sulfafurazole-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenazopyridine- and sulfamethoxazole-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Azo-Sulfamethoxazole |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium citrate 4.4g/sachet powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing phenazopyridine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenazopyridine hydrochloride 95 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenazopyridine hydrochloride 150 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenazopyridine hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenazopyridine hydrochloride 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenazopyridine hydrochloride 97.2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing oxytetracycline hydrochloride and phenazopyridine hydrochloride and sulfamethizole |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing ammonium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing ammonium chloride and diphenhydramine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydroxyapatite 830 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydroxyapatite 3.32 g oral granules sachet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing durapatite (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ammonium chloride- and caffeine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing sodium bicarbonate and sodium citrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing calcium hydroxyapatite and carboxymethylcellulose sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carboxymethylcellulose sodium + hydroxyapatite injectable implant 1mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing carboxymethylcellulose sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent pour l'appareil génito-urinaire |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|